Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lambin

Showing results (651-660 of 939) with videos related to

Pageof 94
Sort By:
International Journal of Radiation Oncology, Biology, Physics|February 15, 2005
Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling studyAntoinet van Der Wel, Sebastiaan Nijsten, Monique Hochstenbag, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2008
Individualized radical radiotherapy of non-small-cell lung cancer based on normal tissue dose constraints: a feasibility studyAngela van Baardwijk, Geert Bosmans, Liesbeth Boersma, et al.
International Journal of Radiation Oncology, Biology, Physics|May 5, 2015
A Validated Prediction Model for Overall Survival From Stage III Non-Small Cell Lung Cancer: Toward Survival Prediction for Individual PatientsCary Oberije, Dirk De Ruysscher, Ruud Houben, et al.
International Journal of Radiation Biology|July 3, 2015
High dose rate and flattening filter free irradiation can be safely implemented in clinical practiceLudwig Dubois, Rianne Biemans, Brigitte Reniers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2010
Mature results of an individualized radiation dose prescription study based on normal tissue constraints in stages I to III non-small-cell lung cancerAngela van Baardwijk, Stofferinus Wanders, Liesbeth Boersma, et al.
Blood|November 26, 1999
Erythroblastic synartesis: an auto-immune dyserythropoiesisE M Cramer, I Garcia, J M Massé, et al.
Molecular Ecology|April 24, 2008
Temporal changes in kin structure through a population cycle in a territorial bird, the red grouse Lagopus lagopus scoticusStuart B Piertney, Xavier Lambin, Andrew D C Maccoll, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 19, 2013
Characterization of tumor heterogeneity using dynamic contrast enhanced CT and FDG-PET in non-small cell lung cancerW van Elmpt, M Das, Martin Hüllner, et al.
Cancer Medicine|January 10, 2014
Comparison of toxicity and outcomes of concurrent radiotherapy with carboplatin/paclitaxel or cisplatin/etoposide in stage III non-small cell lung cancerMun Sem Liew, Joseph Sia, Maud H W Starmans, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 7, 2024
Intratumor genetic heterogeneity and head and neck cancer relapseA S Pierik, J B Poell, A Brink, et al.
Pageof 94

Showing results (651-660 of 939) with videos related to

Sort By:
Pageof 94
International Journal of Radiation Oncology, Biology, Physics|February 15, 2005
Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling studyAntoinet van Der Wel, Sebastiaan Nijsten, Monique Hochstenbag, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2008
Individualized radical radiotherapy of non-small-cell lung cancer based on normal tissue dose constraints: a feasibility studyAngela van Baardwijk, Geert Bosmans, Liesbeth Boersma, et al.
International Journal of Radiation Oncology, Biology, Physics|May 5, 2015
A Validated Prediction Model for Overall Survival From Stage III Non-Small Cell Lung Cancer: Toward Survival Prediction for Individual PatientsCary Oberije, Dirk De Ruysscher, Ruud Houben, et al.
International Journal of Radiation Biology|July 3, 2015
High dose rate and flattening filter free irradiation can be safely implemented in clinical practiceLudwig Dubois, Rianne Biemans, Brigitte Reniers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2010
Mature results of an individualized radiation dose prescription study based on normal tissue constraints in stages I to III non-small-cell lung cancerAngela van Baardwijk, Stofferinus Wanders, Liesbeth Boersma, et al.
Blood|November 26, 1999
Erythroblastic synartesis: an auto-immune dyserythropoiesisE M Cramer, I Garcia, J M Massé, et al.
Molecular Ecology|April 24, 2008
Temporal changes in kin structure through a population cycle in a territorial bird, the red grouse Lagopus lagopus scoticusStuart B Piertney, Xavier Lambin, Andrew D C Maccoll, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 19, 2013
Characterization of tumor heterogeneity using dynamic contrast enhanced CT and FDG-PET in non-small cell lung cancerW van Elmpt, M Das, Martin Hüllner, et al.
Cancer Medicine|January 10, 2014
Comparison of toxicity and outcomes of concurrent radiotherapy with carboplatin/paclitaxel or cisplatin/etoposide in stage III non-small cell lung cancerMun Sem Liew, Joseph Sia, Maud H W Starmans, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 7, 2024
Intratumor genetic heterogeneity and head and neck cancer relapseA S Pierik, J B Poell, A Brink, et al.
Pageof 94